OBJECTIVE:To explore the mechanism by which Qinghua decoction(清化饮)regulates neuroendocrine inflammation in chronic nonbacterial prostatitis(CNP)model rats and provide an experimental basis for clinical treatment.ME...OBJECTIVE:To explore the mechanism by which Qinghua decoction(清化饮)regulates neuroendocrine inflammation in chronic nonbacterial prostatitis(CNP)model rats and provide an experimental basis for clinical treatment.METHODS:The rats were randomly divided into six groups:normal control,model,Qianlie Tongyu capsule,low-dose Qinghua decoction,medium-dose Qinghua decoction,and high-dose Qinghua decoction group with six rats in each group.Rats in each group were sacrificed on the 29th day of treatment,and blood and prostate tissues were collected.Serum levels of tumor necrosis factor-alpha and interleukins 1-beta,6,8,and 10(TNF-αand IL-1β,-6,-8,and-10,respectively)were measured using enzyme-linked immunosorbent assay.The pathological changes in the rat prostate tissue in each group were observed under a light microscope.The expression levels of chromogranin A(CgA),nerve growth factor(NGF),and tyrosine kinase A(TrkA)were detected using reverse transcription quantitative polymerase chain reaction.Western blotting was used to detect protein expression of CgA,NGF,and TrkA.RESULTS:In the model group,the prostate capsule membrane and stroma were significantly dilated with more inflammatory cells infiltrating the stroma and perivessels.TNF-α,IL-1β,-6,and-8,CgA,NGF,and TrkA levels increased,whereas the content of IL-10 decreased,which was statistically significant compared to that in the normal control group(P<0.05).Prostate tissue cells in the high-dose group were neatly arranged with no obvious inflammatory cell infiltration.When compared with the model group,the high-dose Qinghua decoction group showed a significant improvement in these indices(P<0.05).CONCLUSION:Qinghua decoction led to inhibition of pathological changes in the prostate tissue of rats with CNP,regulation of inflammatory cytokine expression,and inhibition in the expression of CgA,NGF,and TrkA.This mechanism may be primarily related to regulation of the CgA/NGF/TrkA signaling pathway mediated by various inflammatory factors.展开更多
目的观察名老中医王成荣经验方清化汤诊治经血量多、经期延长的疗效及安全性。方法观察组采用清化汤治疗,经期第一天开始服用,每日1剂,100 m L,每日3次,饭后温服,每月服用7 d,连续服药3个月经周期。对照组予口服氨甲环酸片0.5 g,每日2次...目的观察名老中医王成荣经验方清化汤诊治经血量多、经期延长的疗效及安全性。方法观察组采用清化汤治疗,经期第一天开始服用,每日1剂,100 m L,每日3次,饭后温服,每月服用7 d,连续服药3个月经周期。对照组予口服氨甲环酸片0.5 g,每日2次,饭后服用。经期第一天开始服用,每月服用7 d,连续服药3个月经周期。结果观察组痊愈17例,显效6例,有效5例,无效2例。对照组痊愈10例,显效9例,有效8例,无效3例。中药清化汤痊愈率为56.67%,优于对照组痊愈率33.33%,2组在研究过程中均未发现明显副作用。结论清化汤治疗经血量多、经期延长疗效确切,安全无毒副作用。展开更多
目的:研究温肾健脾清化汤辅助治疗脾肾气虚型慢性肾脏病(CKD)的临床疗效及对血清转化生长因子β_(1)(TGF-β_(1))、纤维连接蛋白(FN)水平的影响。方法:选取脾肾气虚型CKD患者96例,按照随机数字表法分为常规组和试验组,各48例。常规组采...目的:研究温肾健脾清化汤辅助治疗脾肾气虚型慢性肾脏病(CKD)的临床疗效及对血清转化生长因子β_(1)(TGF-β_(1))、纤维连接蛋白(FN)水平的影响。方法:选取脾肾气虚型CKD患者96例,按照随机数字表法分为常规组和试验组,各48例。常规组采用对症治疗及常规西药治疗,试验组在常规组基础上加服温肾健脾清化汤治疗,均持续治疗6个月。比较两组治疗6个月后临床疗效,治疗前、治疗6个月后中医症候积分、肾功能指标[血肌酐(SCr)、估算肾小球滤过率(eGFR)、24 h尿蛋白定量(24 h UPro)]、血清肾纤维化指标(TGF-β_(1)、FN),并统计治疗期间不良反应。结果:治疗6个月后两组中医症候积分低于治疗前,且试验组低于常规组(P<0.05);试验组总有效率89.58%高于常规组72.92%(P<0.05);治疗6个月后两组SCr、24 h UPro低于治疗前,eGFR高于治疗前,且试验组SCr、24 h UPro低于常规组,eGFR高于治疗前(P<0.05);治疗6个月后两组TGF-β_(1)、FN低于治疗前,且试验组低于常规组(P<0.05);两组不良反应发生率比较差异无统计学意义(P>0.05)。结论:温肾健脾清化汤辅助治疗脾肾气虚型CKD临床疗效显著,能降低中医证候积分,改善肾功能及肾纤维化指标,安全性高。展开更多
基金Hebei Administration of Traditional Chinese Medicine Project:Study on the Neuroendocrine Mechanism of Chronic Prostatitis Rats Regulated by the Method of Clearing heat and Dampness,Activating Blood and Removing Stasis(No.2019087)Hebei Provincial Department of Education for Postgraduate Innovation Ability Training Project:the Mechanism of Improving Pulmonary Function of COPD Rats with Lung Qi Deficiency by Regulating Intestinal Bacteria with Peitu Shengjin Formula(No.CXZZBS2020151)Provincial Universities Basic Research Funds Special Project:Study on the Mechanism of Shenling Baizhu Powder Based on Lung Intestine Axis to Interfere with the Deficiency of Lung and Spleen in Experimental COPD(YJZ2019010)。
文摘OBJECTIVE:To explore the mechanism by which Qinghua decoction(清化饮)regulates neuroendocrine inflammation in chronic nonbacterial prostatitis(CNP)model rats and provide an experimental basis for clinical treatment.METHODS:The rats were randomly divided into six groups:normal control,model,Qianlie Tongyu capsule,low-dose Qinghua decoction,medium-dose Qinghua decoction,and high-dose Qinghua decoction group with six rats in each group.Rats in each group were sacrificed on the 29th day of treatment,and blood and prostate tissues were collected.Serum levels of tumor necrosis factor-alpha and interleukins 1-beta,6,8,and 10(TNF-αand IL-1β,-6,-8,and-10,respectively)were measured using enzyme-linked immunosorbent assay.The pathological changes in the rat prostate tissue in each group were observed under a light microscope.The expression levels of chromogranin A(CgA),nerve growth factor(NGF),and tyrosine kinase A(TrkA)were detected using reverse transcription quantitative polymerase chain reaction.Western blotting was used to detect protein expression of CgA,NGF,and TrkA.RESULTS:In the model group,the prostate capsule membrane and stroma were significantly dilated with more inflammatory cells infiltrating the stroma and perivessels.TNF-α,IL-1β,-6,and-8,CgA,NGF,and TrkA levels increased,whereas the content of IL-10 decreased,which was statistically significant compared to that in the normal control group(P<0.05).Prostate tissue cells in the high-dose group were neatly arranged with no obvious inflammatory cell infiltration.When compared with the model group,the high-dose Qinghua decoction group showed a significant improvement in these indices(P<0.05).CONCLUSION:Qinghua decoction led to inhibition of pathological changes in the prostate tissue of rats with CNP,regulation of inflammatory cytokine expression,and inhibition in the expression of CgA,NGF,and TrkA.This mechanism may be primarily related to regulation of the CgA/NGF/TrkA signaling pathway mediated by various inflammatory factors.
文摘目的:研究温肾健脾清化汤辅助治疗脾肾气虚型慢性肾脏病(CKD)的临床疗效及对血清转化生长因子β_(1)(TGF-β_(1))、纤维连接蛋白(FN)水平的影响。方法:选取脾肾气虚型CKD患者96例,按照随机数字表法分为常规组和试验组,各48例。常规组采用对症治疗及常规西药治疗,试验组在常规组基础上加服温肾健脾清化汤治疗,均持续治疗6个月。比较两组治疗6个月后临床疗效,治疗前、治疗6个月后中医症候积分、肾功能指标[血肌酐(SCr)、估算肾小球滤过率(eGFR)、24 h尿蛋白定量(24 h UPro)]、血清肾纤维化指标(TGF-β_(1)、FN),并统计治疗期间不良反应。结果:治疗6个月后两组中医症候积分低于治疗前,且试验组低于常规组(P<0.05);试验组总有效率89.58%高于常规组72.92%(P<0.05);治疗6个月后两组SCr、24 h UPro低于治疗前,eGFR高于治疗前,且试验组SCr、24 h UPro低于常规组,eGFR高于治疗前(P<0.05);治疗6个月后两组TGF-β_(1)、FN低于治疗前,且试验组低于常规组(P<0.05);两组不良反应发生率比较差异无统计学意义(P>0.05)。结论:温肾健脾清化汤辅助治疗脾肾气虚型CKD临床疗效显著,能降低中医证候积分,改善肾功能及肾纤维化指标,安全性高。